Immix Biopharma, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immix Biopharma, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Immix Biopharma, Inc. Depreciation for the quarter ending March 31, 2024 was $3.01K, a 496% increase year-over-year.
  • Immix Biopharma, Inc. annual Depreciation for 2023 was $5.47K, a 156% increase from 2022.
  • Immix Biopharma, Inc. annual Depreciation for 2022 was $2.14K, a 13.5% decline from 2021.
  • Immix Biopharma, Inc. annual Depreciation for 2021 was $2.47K, a 6.33% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.47K +$3.33K +156% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.14K -$333 -13.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $2.47K +$147 +6.33% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $2.32K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.